Ocumension Therapeutics
HKEX:1477

Watchlist Manager

Ocumension Therapeutics

HKEX:1477

Watchlist

Dividends

Price: 9.03 HKD -0.99% Market Closed

Market Cap: 7.3B HKD

Have any thoughts about
Ocumension Therapeutics?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 9.03 HKD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

Alert

Ocumension Therapeutics

9.03

-0.09 (-0.99%)

52 Week Range	3.72 9.15
Price Target

We'll email you a reminder when the closing price reaches HKD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Ocumension Therapeutics

What unique competitive advantages
does Ocumension Therapeutics hold over its rivals?

What risks and challenges
does Ocumension Therapeutics face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Ocumension Therapeutics.

What unique competitive advantages
does Ocumension Therapeutics hold over its rivals?

What risks and challenges
does Ocumension Therapeutics face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ocumension Therapeutics.

Provide P/S
for Ocumension Therapeutics.

Provide P/E
for Ocumension Therapeutics.

Provide P/OCF
for Ocumension Therapeutics.

Provide P/FCFE
for Ocumension Therapeutics.

Provide P/B
for Ocumension Therapeutics.

Provide EV/S
for Ocumension Therapeutics.

Provide EV/GP
for Ocumension Therapeutics.

Provide EV/EBITDA
for Ocumension Therapeutics.

Provide EV/EBIT
for Ocumension Therapeutics.

Provide EV/OCF
for Ocumension Therapeutics.

Provide EV/FCFF
for Ocumension Therapeutics.

Provide EV/IC
for Ocumension Therapeutics.

Show me price targets
for Ocumension Therapeutics made by professional analysts.

What are the Revenue projections
for Ocumension Therapeutics?

How accurate were the past Revenue estimates
for Ocumension Therapeutics?

What are the Net Income projections
for Ocumension Therapeutics?

How accurate were the past Net Income estimates
for Ocumension Therapeutics?

What are the EPS projections
for Ocumension Therapeutics?

How accurate were the past EPS estimates
for Ocumension Therapeutics?

What are the EBIT projections
for Ocumension Therapeutics?

How accurate were the past EBIT estimates
for Ocumension Therapeutics?

Compare the revenue forecasts
for Ocumension Therapeutics with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ocumension Therapeutics and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ocumension Therapeutics against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ocumension Therapeutics compared to its peers.

Compare the P/E ratios
of Ocumension Therapeutics against its peers.

Discuss the investment returns and shareholder value creation
comparing Ocumension Therapeutics with its peers.

Analyze the financial leverage
of Ocumension Therapeutics compared to its main competitors.

Show all profitability ratios
for Ocumension Therapeutics.

Provide ROE
for Ocumension Therapeutics.

Provide ROA
for Ocumension Therapeutics.

Provide ROIC
for Ocumension Therapeutics.

Provide ROCE
for Ocumension Therapeutics.

Provide Gross Margin
for Ocumension Therapeutics.

Provide Operating Margin
for Ocumension Therapeutics.

Provide Net Margin
for Ocumension Therapeutics.

Provide FCF Margin
for Ocumension Therapeutics.

Show all solvency ratios
for Ocumension Therapeutics.

Provide D/E Ratio
for Ocumension Therapeutics.

Provide D/A Ratio
for Ocumension Therapeutics.

Provide Interest Coverage Ratio
for Ocumension Therapeutics.

Provide Altman Z-Score Ratio
for Ocumension Therapeutics.

Provide Quick Ratio
for Ocumension Therapeutics.

Provide Current Ratio
for Ocumension Therapeutics.

Provide Cash Ratio
for Ocumension Therapeutics.

What is the historical Revenue growth
over the last 5 years for Ocumension Therapeutics?

What is the historical Net Income growth
over the last 5 years for Ocumension Therapeutics?

What is the current Free Cash Flow
of Ocumension Therapeutics?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ocumension Therapeutics.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

Price Targets Summary
Ocumension Therapeutics

Wall Street analysts forecast Ocumension Therapeutics stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ocumension Therapeutics is 7.36 HKD with a low forecast of 7 HKD and a high forecast of 7.88 HKD.

Lowest

Price Target

7 HKD

22% Downside

Average

Price Target

7.36 HKD

19% Downside

Highest

Price Target

7.88 HKD

13% Downside

Ocumension Therapeutics Competitors:
Price Targets

VENUSREM

Venus Remedies Ltd

28% Downside

1795

Lotus Pharmaceutical Co Ltd

38% Upside

4746

Formosa Laboratories Inc

63% Upside

SUNPHARMA

Sun Pharmaceutical Industries Ltd

19% Upside

VENUSREM

Venus Remedies Ltd

28% Downside

1795

Lotus Pharmaceutical Co Ltd

38% Upside

4746

Formosa Laboratories Inc

63% Upside

SUNPHARMA

Sun Pharmaceutical Industries Ltd

19% Upside

Revenue
Forecast

Revenue Estimate
Ocumension Therapeutics

For the last 5 years the compound annual growth rate for Ocumension Therapeutics's revenue is 366%. The projected CAGR for the next 3 years is 58%.

366%

Past Growth

58%

Estimated Growth

Estimates Accuracy

-6%

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Ocumension Therapeutics

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

11%

Average Beat

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Ocumension Therapeutics

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-19%

Average Miss

What are analyst estimates?

What is Ocumension Therapeutics's stock price target?

Price Target
7.36 HKD

According to Wall Street analysts, the average 1-year price target for Ocumension Therapeutics is 7.36 HKD with a low forecast of 7 HKD and a high forecast of 7.88 HKD.

What is Ocumension Therapeutics's Revenue forecast?

Projected CAGR
58%

For the last 5 years the compound annual growth rate for Ocumension Therapeutics's revenue is 366%. The projected CAGR for the next 3 years is 58%.

	Franklin Covey Co NYSE:FC	22.61 USD -2.08%
	Mohawk Industries Inc NYSE:MHK	104.71 USD -1.16%
	Ardmore Shipping Corp NYSE:ASC	9.82 USD 1.97%
	ASGN Inc NYSE:ASGN	53.46 USD -2.73%
	Skyworks Solutions Inc NASDAQ:SWKS	72.82 USD -2.84%
	Weatherford International PLC NASDAQ:WFRD	52.26 USD 1.67%

	Johnson & Johnson NYSE:JNJ	155.26 USD -0.76%
	Bank of America Corp NYSE:BAC	44.73 USD -0.8%
	Mastercard Inc NYSE:MA	590.74 USD 0.2%
	Salesforce Inc NYSE:CRM	265.91 USD -0.86%
	Abbvie Inc NYSE:ABBV	191.5 USD 1.06%
	Home Depot Inc NYSE:HD	360.46 USD -2.02%

	Arista Networks Inc NYSE:ANET	94.21 USD 0.54%
	Deckers Outdoor Corp NYSE:DECK	107.93 USD -1.88%
	Visa Inc NYSE:V	373.31 USD 0.7%
	Texas Pacific Land Corp NYSE:TPL	1 100.01 USD 0.04%
	KLA Corp NASDAQ:KLAC	872 USD 1.8%
	Manhattan Associates Inc NASDAQ:MANH	189.33 USD -2.04%

	Salesforce Inc NYSE:CRM	265.91 USD -0.86%
	Accenture PLC NYSE:ACN	319.22 USD -0.53%
	ServiceNow Inc NYSE:NOW	1 004.33 USD -0.54%
	Spotify Technology SA NYSE:SPOT	709.14 USD 2.28%
	EOG Resources Inc NYSE:EOG	119.92 USD 1.73%
	Applied Materials Inc NASDAQ:AMAT	172.79 USD -0.56%

Ocumension Therapeutics
HKEX:1477

Wall Street
Price Targets

Price Targets Summary
Ocumension Therapeutics

Revenue
Forecast

Revenue Estimate
Ocumension Therapeutics

Operating Income
Forecast

Operating Income Estimate
Ocumension Therapeutics

Net Income
Forecast

Net Income Estimate
Ocumension Therapeutics

See Also

What is Ocumension Therapeutics's stock price target?

Price Target
7.36 HKD

What is Ocumension Therapeutics's Revenue forecast?

Projected CAGR
58%

Company

Help

Tools

Stocks

Ocumension Therapeutics HKEX:1477

Wall Street Price Targets

Price Targets Summary Ocumension Therapeutics

Revenue Forecast

Revenue Estimate Ocumension Therapeutics

Operating Income Forecast

Operating Income Estimate Ocumension Therapeutics

Net Income Forecast

Net Income Estimate Ocumension Therapeutics

See Also

What is Ocumension Therapeutics's stock price target? Price Target 7.36 HKD

What is Ocumension Therapeutics's Revenue forecast? Projected CAGR 58%

Company

Help

Tools

Stocks

Ocumension Therapeutics
HKEX:1477

Wall Street
Price Targets

Price Targets Summary
Ocumension Therapeutics

Revenue
Forecast

Revenue Estimate
Ocumension Therapeutics

Operating Income
Forecast

Operating Income Estimate
Ocumension Therapeutics

Net Income
Forecast

Net Income Estimate
Ocumension Therapeutics

What is Ocumension Therapeutics's stock price target?

Price Target
7.36 HKD

What is Ocumension Therapeutics's Revenue forecast?

Projected CAGR
58%